Evidence map›Paper›PMID 28448534›Full record

Trial reportPloS one2017

Intense light-elicited upregulation of miR-21 facilitates glycolysis and cardioprotection through Per2-dependent mechanisms.

Colleen Marie Bartman, Yoshimasa Oyama, Kelley Brodsky, Ludmila Khailova, Lori Walker, Michael Koeppen, Tobias Eckle

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03822949 (Bright Light Exposure in Patients Undergoing Non-cardiac Elective Surgery), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03822949 narecruitingnot on this mapstarted 2019, after this paper: background citation

Bright Light Exposure in Patients Undergoing Non-cardiac Elective Surgery

TypeinterventionalSponsorUniversity of Colorado, DenverRan2019 to 2026Enrolled70ConditionsMyocardial Ischemia, Critical Illness, Endothelial DysfunctionArmsDay Light, Placebo light, ICU Intense Light, ICU Placebo light
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Light therapy in medicine: where do we stand?Annals of translational medicine · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Cardiac Metabolism and MiRNA Interference.International journal of molecular sciences · 2022
    Review
  16. Intense light-elicited alveolar type 2-specific circadian PER2 protects from bacterial lung injury via BPIFB1.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  17. Review
  18. Circadian disruption and human health.The Journal of clinical investigation · 2021
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Colleen Marie BartmanDepartment of Anesthesiology, University of Colorado Denver School of Medicine, Aurora, CO, United States of America.
Yoshimasa OyamaDepartment of Anesthesiology, University of Colorado Denver School of Medicine, Aurora, CO, United States of America.
Kelley BrodskyDepartment of Anesthesiology, University of Colorado Denver School of Medicine, Aurora, CO, United States of America.
Ludmila KhailovaDepartment of Anesthesiology, University of Colorado Denver School of Medicine, Aurora, CO, United States of America.
Lori WalkerDivision of Cardiology, Department of Medicine, University of Colorado Denver School of Medicine, Aurora, CO, United States of America.
Michael KoeppenDepartment of Anesthesiology, Ludwig Maximilian University of Munich, Munich, Germany.
Tobias EckleDepartment of Anesthesiology, University of Colorado Denver School of Medicine, Aurora, CO, United States of America.ORCID http://orcid.org/0000-0002-6065-4669
University of Colorado Denver · USLudwig-Maximilians-Universität München · DEOita University · JP

Funding

Intense Light Therapy for Perioperative Cardio-ProtectionR01HL122472 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DE LA GARZA ECKLE, TOBIAS · 2015 to 2019
$1.9M
Colorado Clinical and Translational Sciences InstituteTL1TR001081 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$1.3M
NCATS NIH HHS TL1 TR001081NHLBI NIH HHS R01 HL122472
6 · The paper itself

Abstract

A wide search for ischemic preconditioning (IPC) mechanisms of cardioprotection identified the light elicited circadian rhythm protein Period 2 (Per2) to be cardioprotective. Studies on cardiac metabolism found a key role for light elicited Per2 in mediating metabolic dependence on carbohydrate metabolism. To profile Per2 mediated pathways following IPC of the mouse heart, we performed a genome array and identified 352 abundantly expressed and well-characterized Per2 dependent micro RNAs. One prominent result of our in silico analysis for cardiac Per2 dependent micro RNAs revealed a selective role for miR-21 in the regulation of hypoxia and metabolic pathways. Based on this Per2 dependency, we subsequently found a diurnal expression pattern for miR-21 with higher miR-21 expression levels at Zeitgeber time (ZT) 15 compared to ZT3. Gain or loss of function studies for miR-21 using miRNA mimics or miRNA inhibitors and a Seahorse Bioanalyzer uncovered a critical role of miR-21 for cellular glycolysis, glycolytic capacity, and glycolytic reserve. Exposing mice to intense light, a strategy to induce Per2, led to a robust induction of cardiac miR-21 tissue levels and decreased infarct sizes, which was abolished in miR-21-/- mice. Similarly, first translational studies in humans using intense blue light exposure for 5 days in healthy volunteers resulted in increased plasma miR-21 levels which was associated with increased phosphofructokinase activity, the rate-limiting enzyme in glycolysis. Together, we identified miR-21 as cardioprotective downstream target of Per2 and suggest intense light therapy as a potential strategy to enhance miR-21 activity and subsequent carbohydrate metabolism in humans.

Indexed as

LightAdultAnimalsEndothelial CellsFemaleGlycolysisHeartHumansIschemic PreconditioningLungMaleMiceMice, Inbred C57BLMicroRNAsMyocardial InfarctionMyocardiumMicroRNAsMIRN21 microRNA, mousePeriod Circadian ProteinsPhosphofructokinases

Identifiers

PMID28448534
PMCPMC5407766
OpenAlexW2608240479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.